PRIA Logo™
TennesseeSB 2499114th General Assembly (2025-2026)Senate

AN ACT to amend Tennessee Code Annotated, Title 4; Title 56 and Title 71, relative to the coverage of long-acting injectable drugs for the treatment or prevention of human immunodeficiency virus.

Sponsored By: Sara Kyle (Democrat)

In Committee

TennCare

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Sara Kyle

    Democrat • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Assigned to General Subcommittee of Senate Commerce and Labor Committee

    3/10/2026Senate

  2. Passed on Second Consideration, refer to Senate Commerce and Labor Committee

    3/5/2026Senate

  3. Placed on Senate Commerce and Labor Committee calendar for 3/10/2026

    3/4/2026Senate

  4. Approved by Delayed Bills Committee

    3/2/2026Senate

  5. Introduced, Passed on First Consideration

    3/2/2026Senate

  6. Filed for introduction

    2/2/2026Senate

  7. Refer to Senate Delayed Bills Committee

    2/2/2026Senate

Bill Text

Related Bills

Back to State Legislation